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vestigate whether oral administration of the NSAID, naproxen, or
a matrix metalloproteinase (MMP) inhibitor would alter cartilage
erosion and/or weight bearing asymmetry in the rat MT model of
osteoarthritis.
Methods: Pathology was induced in male Lewis rats, (270g,
n=10/group) by surgically transecting the medial collateral lig-
ament and a full thickness cut through the meniscus of the
left knee, day 0. Sham animals underwent the same proce-
dure with omission of the meniscus transection. MT animals
were dosed orally bid with vehicle (HPMC/tween, 1%DMSO),
naproxen (10mg/kg) or an equipotent MMP 2, 8, 9, 13 inhibitor,
(0.125, 0.5, 2.5 mg/kg), from day -1. Changes in weight bearing
asymmetry were assessed at -2, 7, 14, 21, 28, and 35 days
post surgery, using an incapacitance meter. Rats were sacriﬁced
35 days post surgery and the leg removed for histological as-
sessment. Toluidine blue stained coronal step sections (10µm)
across the entire knee joint were assessed for cartilaginous
changes and lesion size measured by image analysis, using in
house software. Treatment effect was determined using ANOVA
(Dunnet’s post hoc analysis), for weight bearing (AUC) and lesion
size, whereby P<0.05 was considered statistically signiﬁcant.
Results: Osteoarthritic-like lesions developed in the vehicle
treated MT animals on the medial side of the tibial plateau of the
operated leg, resulting in loss of proteoglycan, fracturing, and
erosion of cartilage. Sham operated animals had histologically
normal cartilage. Treatment of MT animals with naproxen had no
effect on pathology scores, whereas the MMP inhibitor treatment
reduced cartilage fracture score (P<0.05 all doses) and cartilage
lesion size by 52-65% (P<0.05 at 0.5, 2.5 mg/kg bid). There was
a clear division in weight bearing asymmetry proﬁles of sham
and vehicle treated MT animals from 14 days onwards. Sham
animals gradually returned to symmetrical weight bearing by day
28 whilst vehicle treated MT animals maintained a 40 to 50g
asymmetry between operated and contralateral legs (P<0.001).
The weight bearing asymmetry was signiﬁcantly ameliorated by
naproxen (P<0.001) and the MMP inhibitor (P<0.01), evident
from day 14 onwards.
Conclusions: Asymmetry was ameliorated with naproxen treat-
ment, thus demonstrating the utility of the animal model to inves-
tigate novel treatments for reducing joint pain. Notably, treatment
with an MMP inhibitor showed chondro-protection and reduced
weight-bearing asymmetry. These data suggest that chondro-
protective agents could improve functional joint mobility. Further
work is required to understand the analgesic mechanism.
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Purpose: While pain in knee osteoarthritis (OA) has long been
considered a chronic condition, the symptoms experienced by
OA patients are neither constant nor stable, but rather ﬂuctuate.
These observations suggest that factors that vary over time within
a person are responsible for pain ﬂuctuation. Few studies have
been conducted to examine the effect of time-varying factors
on knee pain ﬂuctuation. We examined whether changes in MRI
features (i.e., synovitis, effusion, and bone marrow lesions (BML))
are associated with change in knee pain among the subjects of
Multicenter Osteoarthritis Study (MOST).
Methods: MOST is a longitudinal study of risk factors for knee
structural changes and occurrence of pain. Subjects included in
this analysis were asked about frequent knee pain in the past
month (pain, aching and stiffness on most days) by interview
and had knee MRIs performed at the baseline visit and at one
or two follow-up visits. All subjects had a 30-month follow-up
while a subset of subjects with new knee pain and a random
sample of controls without knee pain had a 15-month visit.
MRIs were scored using the WORMS scale by two radiologists
(range of interobserver ICC: 0.68-0.96) blinded to knee pain
status. Synovitis was scored 0-3 in two sites (infrapatella and
intercondylar), effusion was scored 0-3 for each knee, and BML’s
were scored 0-3 in each of 5 sub-regions in the medial and
lateral and 4 subregions in the patellofemoral compartments. We
summarized synovitis and BMLs within each knee by totaling
the scores across sites or sub-regions. We deﬁned a visit as a
case-visit if a knee had pain on most days of the past month
prior to that clinic visit, and as a control-visit if the same knee did
not have pain on most days of the past month prior to that clinic
visit(s). The visits with no knee pain served as the controls for
the case-visits of the same knee. We evaluated the relation of
summary score of synovitis, effusion, and BML to the knee pain
ﬂuctuation using a conditional logistic regression model.
Results: 250 knees (232 subjects) that had knee pain in at least
one, but not all, clinic visits (255 case-visits and 261 control-visits)
were analyzed. Of them, 25 knees had pain and MRI assessed
at 3 visits and 225 knees assessed at 2 visits. Over the follow-up
period, 7.4%, 9%, and 21% of the knees had total synovitis,
effusion and BML scores improve, respectively; whereas 8.2%,
5.4%, and 25% of the knees had synovitis, effusion and BML
scores worsen. Changes in synovitis, effusion and BML scores
were strongly associated with knee pain ﬂuctuation. The odds
ratios (OR) of knee pain occurrence were 1.0, 4.4, 8.1 and 23.7
when synovitis score increased from 0 to 1, 2, and 3-6 at the
same knee, respectively (p for trend <0.001); the ORs of knee
pain were 1.9 and 9.2 respectively for an increase in effusion
score to 1 or 2-3 compared with an effusion score of 0 (p for
trend <0.001); the ORs of knee pain occurrence increased from
1.0 to 2.1, 2.7, 4.6, 11.3, 12.9 and 16.5 when the BML score
increased from 0 to 1, 2, 3, 4, 5 and 6-13 (p for trend <0.001),
respectively.
Conclusions: We found that changes of synovitis, effusion, and
BML were strongly associated with the ﬂuctuation of knee pain.
Since these MRI features are reversible, clinical intervention
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Purpose: With the advent of MRI, lesions have been described
in subchondral bone characterized by high signal intensity on
T2 weighted images, and termed, bone marrow edema (BME).
These lesions are seen in osteoarthritis (OA), avascular necrosis
(AVN), stress fractures, infection, and inﬂammatory arthropathies
as well as in the bone marrow edema syndrome. The clinical
signiﬁcance of BME lies in its association with bone pain. The
pathophysiologic signiﬁcance of BME is its potential association
with altered ﬂuid dynamics and physicochemical signaling in
subchondral bone. This study was undertaken to characterize
BME in both OA and AVN by assessing perfusion in subchondral
bone with dynamic contrast-enhanced MRI.
C18 Podium Presentations
Methods: We have utilized dynamic contrast-enhanced MR
imaging with gadolinium diethylene triamine pentaacetic acid
(Gd-DTPA) and pharmacokinetic modeling to extract kinetic
parameters of bone perfusion in patients with BME. 30 pa-
tients, half with OA and half with AVN by clinical and ra-
diographic criteria, underwent MR imaging with Gd-DTPA us-
ing a volumetric interpolated breath-hold examination (VIBE)
sequence, a three-dimensional, radiofrequency-spoiled gradi-
ent echo sequence. Acquisition parameters include 5.50/2.89
(TR/TE); 10Ã f â ˘A∼Ã‘Â° ﬂip-angle, 350 Hz/pixel bandwidth; 16cm
ﬁeld of view; one excitation; and 151 x 256 matrix (pixel size of
1.0mm x 0.6mm). Following infusion of Gd-DTPA, signal en-
hancement was observed in areas of bone marrow edema.
Regions of interest were identiﬁed in high signal intensity and
adjacent normal bone. After online reconstruction, data sets were
analyzed with in-house software (J. Dyke) exported to a worksta-
tion for analysis. Time-signal intensity curves were created which
characterized the response to the contrast material bolus. Phar-
macokinetic modeling was used to extract dynamic parameters
of blood ﬂow using the Brix two-compartment pharmacokinetic
model which describes the kinetics of Gd-DTPA exchange be-
tween the plasma and interstitial space and is characterized by
several rate and volume transfer constants.
Results: Compared to normal bone, bone with BME retains the
Gd-DTPA longer and to a greater degree resulting in greater
signal enhancement that does not begin to resolve by ﬁve min-
utes of scan time. Signiﬁcant differences between normal bone
and bone with BME were seen in the inﬂow slope (p=0.001),
the amplitude of enhancement (p=0.0001), and the outﬂow con-
stant (p=0.001). Since signal enhancement is proportional to Gd
concentration, the prolongation and enhancement of the out-
ﬂow phase is interpreted as reﬂecting stasis and decreased
perfusion. Signiﬁcant differences were seen among these pa-
rameters between OA and AVN reﬂecting different patterns of
signal enhancement and resolution and suggesting differences
in underlying pathophysiology.
Conclusions: This study demonstrates that dynamic contrast
enhanced MR imaging with Gd-DTPA can be used to char-
acterize human BME and to extract information on bone ﬂuid
dynamics. Time-intensity curves, representing perfusion plots,
describe OA and AVN. Pharmacokinetic modeling techniques
can characterize ﬂuid dynamic changes in OA and AVN and
may yield insight into pathophysiology. Our observations sug-
gest decreased perfusion suggesting changes in the physical
microenvironment of subchondral bone that may be a patho-
physiologic signiﬁcance in joint diseases given the sensitivity of
osteocytes to physicochemical regulation.
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Purpose: Higher axial and appendicular bone mineral density
(BMD) is associated with radiographic hip osteoarthritis (RHOA),
especially osteophytic disease. Bone size and mineral distribution
are important determinants of bone strength and it is not known
if femoral neck geometry is associated with hip OA. Therefore,
we examined whether differences in proximal femoral geometry
were associated with prevalence, incidence or progression of
RHOA and its subtypes.
Methods: Subjects were participants in the Study for Osteo-
porotic Fractures (SOF) who had pelvis radiographs taken at
visits 1 and 5 (an average of 8.3 yrs apart) as well as BMD of
the proximal femur measured at visit 2. Prevalent RHOA was
deﬁned as presence of grades ≥2 osteophytes and joint space
narrowing (JSN) and incident RHOA as the development of these
features in a hip without them at baseline. We also identiﬁed a
separate atrophic RHOA phenotype deﬁned as the presence of
deﬁnite JSN but no osteophytes at both time points. We used
two measures of radiographic progression, joint space narrowing
of at least 0.5 mm and an increase in the total OST score of
≥ 2. The Hip Structural Analysis program was used to measure
femoral neck geometry parameters of neck length, narrow neck
(NN) width and centroid position, an index of medial vs lateral
distribution of bone mineral, from DXA scans at visit 2. OR (95%
CI) for RHOA endpoints are expressed per SD score of geo-
metric measure and adjusted for knee height, age and femoral
NN aBMD by hip. For subtype analysis, we compared atrophic
hips with those hips not meeting either RHOA deﬁnition. We also
compared models with RHOA identiﬁed as ipsi- or contra-lateral
side to the hip geometry measurement.
Results: Radiographic and geometric data were available for
5280 women aged 72.6±4.5 (mean ± SD) years at the time of
DXA measurement (Visit 2). 123 women (141 hips) had RHOA at
baseline and 272 women (299 hips) developed incident RHOA.
An additional 106 hips meet the atrophic criteria at baseline
and 136 hips developed incident atrophic RHOA. Increased NN
width was signiﬁcantly (p<0.001) associated with both prevalent
and incident RHOA. The associations between NN width were
stronger for ipsi-lateral (adj OR 1.76 (1.45- 2.13) per SD NN
width) than contralateral (adj OR 1.30 (1.03-1.65) per SD NN
width) hips. Lower centroid position (ie more medially placed
mineral) was also signiﬁcantly associated with both prevalent
and incident RHOA. In multiple variable model, both NN width,
centroid position and aBMD were independent predictors of
prevalent and incident RHOA. No signiﬁcant associations were
found for either prevalent or incident atrophic phenotype hips. NN
centroid position was a signiﬁcant (p<0.05) determinant of both
osteophyte and joint space types of progression, while NN width
was associated with an increase in osteophyte count (p<0.001)
but not change in joint space narrowing (p=0.3).
Relationship between Incident Radiographic Hip Phenotype with baseline mea-
sures of bone geometry at the narror neck
Conclusions: Differences in bone geometry and mineral distri-
bution at the femoral neck occur early in hip OA and predict
the onset of an RHOA phenotype deﬁned by the presence os-
teophtyes but not an atrophic phenotype with only JSN.
